To include your compound in the COVID-19 Resource Center, submit it here.

InKine, Zeria Pharmaceuticals Co. Ltd. deal

Zeria received exclusive rights to develop,

Read the full 64 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE